TGM2 and cancer: Moreover, TGM2 has been suggested to be involved in epithelial–mesenchymal transition (EMT) and the cancer stem cell phenotype, which are highly associated with aggressive cancer phenotypes, in breast, ovarian and squamous cell carcinomas38–40.